z-logo
open-access-imgOpen Access
Effects of antiepileptic drugs on cortical excitability in humans: A TMS‐EMG and TMS‐EEG study
Author(s) -
Darmani Ghazaleh,
Bergmann Til O.,
Zipser Carl,
Baur David,
MüllerDahlhaus Florian,
Ziemann Ulf
Publication year - 2019
Publication title -
human brain mapping
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.005
H-Index - 191
eISSN - 1097-0193
pISSN - 1065-9471
DOI - 10.1002/hbm.24448
Subject(s) - tiagabine , neuroscience , n100 , transcranial magnetic stimulation , electroencephalography , carbamazepine , psychology , sodium channel , pharmacology , anesthesia , medicine , chemistry , stimulation , epilepsy , sodium , event related potential , organic chemistry
Brain responses to transcranial magnetic stimulation (TMS) recorded by electroencephalography (EEG) are emergent noninvasive markers of neuronal excitability and effective connectivity in humans. However, the underlying physiology of these TMS‐evoked EEG potentials (TEPs) is still heavily underexplored, impeding a broad application of TEPs to study pathology in neuropsychiatric disorders. Here we tested the effects of a single oral dose of three antiepileptic drugs with specific modes of action (carbamazepine, a voltage‐gated sodium channel (VGSC) blocker; brivaracetam, a ligand to the presynaptic vesicle protein VSA2; tiagabine, a gamma‐aminobutyric acid (GABA) reuptake inhibitor) on TEP amplitudes in 15 healthy adults in a double‐blinded randomized placebo‐controlled crossover design. We found that carbamazepine decreased the P25 and P180 TEP components, and brivaracetam the N100 amplitude in the nonstimulated hemisphere, while tiagabine had no effect. Findings corroborate the view that the P25 represents axonal excitability of the corticospinal system, the N100 in the nonstimulated hemisphere propagated activity suppressed by inhibition of presynaptic neurotransmitter release, and the P180 late activity particularly sensitive to VGSC blockade. Pharmaco‐physiological characterization of TEPs will facilitate utilization of TMS‐EEG in neuropsychiatric disorders with altered excitability and/or network connectivity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here